[Federal Register Volume 64, Number 147 (Monday, August 2, 1999)]
[Notices]
[Pages 41939-41940]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-19689]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
International Workshop on the Standardization of Whole Blood
Coagulation Devices
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a
workshop entitled ``International Workshop on the Standardization of
Whole Blood Coagulation Devices.'' The focus of the workshop is to
define the issues relating to the calibration of whole blood
coagulation assays. Workshop participants will be asked to develop a
proposal for standardizing the calibration of these devices. The
proposal will be referred to a standards development organization.
DATE: The workshop will be held on August 13, 1999, 1 p.m. to 6 p.m.
ADDRESSES: The workshop will be held at the Washington Plaza Hotel, 10
Thomas Circle NW., Washington, DC 20005.
FOR FURTHER INFORMATION CONTACT: Sheila J. Murdock, Office of
Surveillance and Biometrics (HFZ-510), Center for Devices and
Radiological Health, Food and Drug Administration, 1350 Piccard Dr.,
Rockville, MD 20850, 301-594-3060, FAX 301-594-2968, e-mail
coagulation@cdrh.fda.gov''.
SUPPLEMENTARY INFORMATION: Whole blood clotting assays are used
increasingly in the point of care testing environment. The calibration
of these assays against plasma methods is achieved through a variety of
approaches. Consequently, the consistency of results between different
devices and the traceability of results to plasma methods are variable.
Limited correlation between assays can be particularly problematic when
monitoring anticoagulant drugs.
The workshop will focus on defining the issues relating to the
calibration of whole blood coagulation devices. Workshop participants
will collaborate on a proposal for the development of a standardized
approach to the calibration of these assays. The proposal will be
referred to a standards development organization.
In order to make the best use of limited workshop time, guest
speakers will be asked to write a draft standardization proposal prior
to the date of the workshop. This document will be posted on the CDRH
website after July 15, 1999, at ``http://www.fda.gov/cdrh/meetings/
coag.html''. Members of the public will be encouraged to e-mail
comments and recommendations about this document to
coagulation@cdrh.fda.gov''. Summaries of all e-mailed comments sent
with author's name will be posted to the website in order to provide a
forum for ongoing discussion up to the week of the workshop.
Those persons interested in attending the workshop should fax or e-
mail their registration including name, title, affiliation (i.e., end-
user, government nonregulatory, government regulatory, industry,
professional organization, proficiency testing organization, trade
press, standards development organization), mailing address, telephone
number, fax number, e-mail address, and area of interest. There is no
charge to attend the workshop, however, advance registration is
requested due to limited seating. If you need special accommodations
due to a disability, please contact Shirley L. Meeks at least 7 days in
advance of the meeting, at the Office of Systems Management (HFZ-17),
Center for Devices and Radiological Health, Food and Drug
Administration, 2098 Gaither Rd., Rockville, MD 20850, 301-594-1283,
ext. 105, FAX 301-827-2929, e-mail ``[email protected]''.
Registration forms and the preliminary agenda may also be accessed
at the CDRH website at ``http://www.fda.gov/cdrh/meetings/coag.html''.
The workshop agenda includes presentations by guest speakers, small
breakout group discussions and deliberation and refining of a
standardization proposal. The final plenary session will include
reports to the assembly from the smaller group discussions. Time will
be provided for public comments at the end of this session. The draft
standardization proposal will be finalized according to the
[[Page 41940]]
recommendations of workshop participants. A summary report of the
workshop will be available on CDRH's website approximately 15 working
days after the workshop. The CDRH home page may be accessed at ``http:/
/www.fda.gov/cdrh''.
Dated: July 23, 1999.
Linda S. Kahan,
Deputy Director for Regulations Policy, Center for Devices and
Radiological Health.
[FR Doc. 99-19689 Filed 7-30-99; 8:45 am]
BILLING CODE 4160-01-F
